InsidersTradesSigma
Follow the 艾德生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 艾德生物 has published 3 public disclosures. Market capitalisation: €6.7bn. The latest transaction was reported on 8 August 2023 (Purchase). Among the most active insiders: 杜立威. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
艾德生物 is a company specializing in the health and pharmaceutical sector, focused on developing biopharmaceutical solutions. It is listed on the XSHE market.